Informazioni sul prodotto
- (9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-a-[(dibutylamino)methyl]-9H-fluorene-4-methanol
- (9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-9H-fluorene-4-methanol
- (Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-alpha-[(dibutylamino)methyl]-9H-fluorene-4-methanol
- 2-(dibutylamino)-1-{(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl}ethanol
- 2-Dibutylamino-1-[2,7-dichloro-9-[1-(4-chlorophenyl)meth-(Z)-ylidene]-9H-fluoren-4-yl]ethanol
- 9H-Fluorene-4-methanol, 2,7-dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-, (9Z)-
- 9H-Fluorene-4-methanol, 2,7-dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-, (Z)-
- Benflumelol
- dl-Benflumelol
Lumefantrine is a drug that belongs to the class of antimalarial drugs. It is used for the treatment of malaria caused by Plasmodium falciparum, and has been shown to be effective against chloroquine-resistant strains. Lumefantrine inhibits polymerase chain reaction by binding to the β subunit of DNA polymerase, thereby preventing mRNA transcription. The rate constant for lumefantrine was calculated using data from environmental stressors such as heat and cold, and from long-term toxicity studies in rats. Lumefantrine has also been shown to have cardiac effects through its ability to inhibit the activity of α1-acid glycoprotein. This drug inhibits p-glycoprotein (Pgp), which is an ATP-dependent efflux pump located on the cell membrane that pumps out drugs from cells. Pgp inhibitors are useful in combination with other chemotherapeutic agents, such as doxorubicin or vincristine
Proprietà chimiche
Richiesta tecnica su: 3D-FL24956 Lumefantrine
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.